Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesc Valldeoriola

Showing results (71-80 of 170) with videos related to

Pageof 17
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|January 21, 2015
Resting-state frontostriatal functional connectivity in Parkinson's disease-related apathyHugo Cesar Baggio, Bàrbara Segura, Jose Luis Garrido-Millan, et al.
Neuroimage|May 11, 2011
Dysfunctions of cerebral networks precede recognition memory deficits in early Parkinson's diseaseNaroa Ibarretxe-Bilbao, Mojtaba Zarei, Carme Junque, et al.
NPJ Parkinson'S Disease|January 27, 2024
Image-guided programming deep brain stimulation improves clinical outcomes in patients with Parkinson's diseaseViviana Torres, Kirsys Del Giudice, Pedro Roldán, et al.
Journal of the Neurological Sciences|July 18, 2016
White matter hyperintensities, cerebrospinal amyloid-β and dementia in Parkinson's diseaseYaroslau Compta, Mariateresa Buongiorno, Núria Bargalló, et al.
The Journal of ECT|April 26, 2012
Use of electroconvulsive therapy in Parkinson disease with residual axial symptoms partially unresponsive to L-dopa: a pilot studyLuis Pérez Pintor, Francesc Valldeoriola, Emilio Fernández-Egea, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 9, 2007
Role of DAT-SPECT in the diagnostic work up of parkinsonismChristoph Scherfler, Johannes Schwarz, Angelo Antonini, et al.
Brain Sciences|May 28, 2020
Erratum: Pagonabarraga, J.; et al. A Spanish Consensus on the Use of Safinamide for Parkinson's Disease in Clinical Practice. <i>Brain Sci.</i> 2020, <i>10</i>, 176Javier Pagonabarraga, José Matías Arbelo, Francisco Grandas, et al.
NPJ Parkinson'S Disease|February 22, 2022
Safinamide in the treatment pathway of Parkinson's Disease: a European Delphi ConsensusFabrizio Stocchi, Angelo Antonini, Daniela Berg, et al.
Brain Sciences|March 22, 2020
A Spanish Consensus on the Use of Safinamide for Parkinson's Disease in Clinical PracticeJavier Pagonabarraga, José Matías Arbelo, Francisco Grandas, et al.
Brain : a Journal of Neurology|October 28, 2009
Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementiaYaroslau Compta, Joan Santamaria, Luca Ratti, et al.
Pageof 17

Showing results (71-80 of 170) with videos related to

Sort By:
Pageof 17
Movement Disorders : Official Journal of the Movement Disorder Society|January 21, 2015
Resting-state frontostriatal functional connectivity in Parkinson's disease-related apathyHugo Cesar Baggio, Bàrbara Segura, Jose Luis Garrido-Millan, et al.
Neuroimage|May 11, 2011
Dysfunctions of cerebral networks precede recognition memory deficits in early Parkinson's diseaseNaroa Ibarretxe-Bilbao, Mojtaba Zarei, Carme Junque, et al.
NPJ Parkinson'S Disease|January 27, 2024
Image-guided programming deep brain stimulation improves clinical outcomes in patients with Parkinson's diseaseViviana Torres, Kirsys Del Giudice, Pedro Roldán, et al.
Journal of the Neurological Sciences|July 18, 2016
White matter hyperintensities, cerebrospinal amyloid-β and dementia in Parkinson's diseaseYaroslau Compta, Mariateresa Buongiorno, Núria Bargalló, et al.
The Journal of ECT|April 26, 2012
Use of electroconvulsive therapy in Parkinson disease with residual axial symptoms partially unresponsive to L-dopa: a pilot studyLuis Pérez Pintor, Francesc Valldeoriola, Emilio Fernández-Egea, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 9, 2007
Role of DAT-SPECT in the diagnostic work up of parkinsonismChristoph Scherfler, Johannes Schwarz, Angelo Antonini, et al.
Brain Sciences|May 28, 2020
Erratum: Pagonabarraga, J.; et al. A Spanish Consensus on the Use of Safinamide for Parkinson's Disease in Clinical Practice. <i>Brain Sci.</i> 2020, <i>10</i>, 176Javier Pagonabarraga, José Matías Arbelo, Francisco Grandas, et al.
NPJ Parkinson'S Disease|February 22, 2022
Safinamide in the treatment pathway of Parkinson's Disease: a European Delphi ConsensusFabrizio Stocchi, Angelo Antonini, Daniela Berg, et al.
Brain Sciences|March 22, 2020
A Spanish Consensus on the Use of Safinamide for Parkinson's Disease in Clinical PracticeJavier Pagonabarraga, José Matías Arbelo, Francisco Grandas, et al.
Brain : a Journal of Neurology|October 28, 2009
Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementiaYaroslau Compta, Joan Santamaria, Luca Ratti, et al.
Pageof 17